While a host of parties is urging the New Jersey Supreme Court to adopt the Daubert standard for admissibility of expert testimony, some lawyers say a change is unnecessary.
An assortment of large employers, business groups and law professors asked the state’s highest court last month to adopt the Daubert standard in amicus briefs for a mass tort concerning the acne drug Accutane. The pro-Daubert campaign consists of four amicus briefs in In Re: Accutane Litigation, where Hoffmann-La Roche Inc. is seeking to overturn an Appellate Division decision finding testimony from plaintiffs’ experts admissible.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
